Hypophosphatemia in Critically Ill Patients

Phosphate is vital for numerous cellular processes, including energy metabolism, membrane integrity and acid–base balance. In critical illness, hypophosphatemia is frequently encountered owing to shifts into cells, increased renal excretion and impaired intake. This electrolyte disturbance may contribute to respiratory muscle weakness, cardiac dysfunction and neurological impairment, thereby complicating mechanical ventilation and prolonging intensive care unit (ICU) stays. Early recognition is essential, as severe or prolonged hypophosphatemia correlates with increased morbidity and mortality across a range of critical conditions, notably sepsis and acute kidney injury. Clinical management hinges on monitoring serum phosphate concentrations and judicious administration of intravenous or enteral phosphate to correct deficits, though optimal thresholds for intervention and dosing strategies remain to be defined. Emerging evidence emphasises not only absolute values but also rapid fluctuations in phosphate levels as important predictors of patient outcomes.

Research from Nature Portfolio

Recent studies have demonstrated a strong link between serum phosphate dynamics and mortality in patients with septic shock. Analyses of large intensive care databases reveal that both elevated phosphate levels and greater early phosphate fluctuations are independently associated with higher 28-day mortality. Non-linear modelling indicates a threshold effect, whereby deviations beyond certain bounds of serum phosphate confer markedly increased risk. These findings highlight the prognostic value of monitoring both static and dynamic phosphate parameters during the initial phase of critical illness, suggesting that stabilising phosphate homeostasis may represent a target for improving survival in severe sepsis.

Hypophosphatemia in Critically Ill Patients publication trend

The graph below shows the total number of articles in hypophosphatemia in critically ill patients across all publications each year (not limited to Nature Index journals).

Technical terms

Hypophosphatemia: A serum phosphate concentration below the normal reference range, often defined as <0.8 mmol/L.

Delta serum phosphate: The difference between the maximum and minimum serum phosphate measurements over a specified period, reflecting dynamic changes.

Continuous renal replacement therapy (CRRT): A slow, continuous dialysis modality used in critically ill patients with acute kidney injury to provide fluid and solute removal over 24 hours.

Inflection point: A value on a dose–response curve at which the rate of change of an outcome measure, such as mortality risk, alters significantly.

References

1. Association of serum phosphate and changes in serum phosphate with 28-day mortality in septic shock from MIMIC-IV database. Scientific Reports (2023).
2. The association between serum phosphate and length of hospital stay and all-cause mortality in adult patients: a cross-sectional study. Nutrition Journal (2024).
3. Impact of hypophosphatemia on outcome of patients in intensive care unit: a retrospective cohort study. BMC Anesthesiology (2019).
4. Treatment of hypophosphatemia in the intensive care unit: a review. Critical Care (2010).